NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD ON [x], 2018
To the
Stockholders of MEI Pharma, Inc.:
On behalf of the Board of Directors of MEI Pharma, Inc., a Delaware corporation (MEI
Pharma), MEI Pharma is pleased to deliver the accompanying proxy statement in connection with the annual meeting of stockholders of MEI Pharma which will be held on [x], 2018 at 9:00 a.m., Pacific Time, at the offices of MEI Pharma, Inc.,
located at 3611 Valley Centre Drive, Suite 500, San Diego, CA 92130, for the following purposes:
1. To elect three directors to our Board
of Directors, to serve until the expiration of their terms in fiscal year 2022 and until their successors are elected and qualified;
2. To
approve the Amended and Restated MEI Pharma, Inc. 2008 Omnibus Equity Compensation Plan (the 2008 Equity Plan) to increase the number of shares of common stock that may be subject to award and make certain other changes to the plan terms
included in the plan document attached as Annex A;
3. To approve an amendment and restatement of our certificate of incorporation to
increase the total number of authorized shares of common stock from 113,000,000 shares to 226,000,000 shares and to remove certain provisions that are no longer applicable (the Authorized Share Increase Proposal);
4. To approve, on an advisory basis, the compensation of the Companys named executive officers as disclosed in the accompanying proxy
statement;
5. To ratify the appointment of BDO USA, LLP, an independent registered public accounting firm, as our independent auditors for
the fiscal year ending June 30, 2019; and
6. To transact such other business as may properly come before the meeting or any
adjournment or postponement thereof.
The proposals are described in more detail in this proxy statement, which MEI Pharma encourages you
to read carefully and in its entirety before voting.
This year, we are again using the Securities and Exchange Commissions Notice
and Access model (Notice and Access), which allows us to deliver proxy materials via the Internet. We believe Notice and Access provides stockholders with a convenient method to access the proxy materials and vote, while allowing us to
conserve natural resources and reduce the costs of printing and distributing the proxy materials. On or about [x], 2018, we mailed stockholders of record a Notice of Internet Availability of Proxy Materials with instructions on how to access the
proxy materials electronically.
The close of business on [x], 2018 has been fixed as the record date for determining those holders of MEI
Pharma common stock entitled to receive notice of and vote at the annual meeting. Accordingly, only record holders of MEI Pharma common stock at the close of business on that date are entitled to notice of and to vote at the annual meeting and at
any adjournments or postponements thereof.
All holders of MEI Pharma common stock are cordially invited to attend the annual meeting in
person. You may revoke your proxy in the manner described in this proxy statement at any time before it is voted at the annual meeting.
Important Notice Regarding Internet Availability of Proxy Materials for the Annual Meeting to be Held on [x], 2018:
MEI Pharmas
Proxy Statement, 2018 Annual Report and Form of Proxy Card are also available at
https://www.edocumentview.com/MEIP
.
Your
vote is important regardless of the number of shares of common stock you own. Whether or not you expect to attend the annual meeting, please submit your proxy by Internet, telephone or mail following the instructions found on your Notice of Internet
Availability of Proxy Materials or proxy card so that your shares of common stock may be represented and voted at the annual meeting.
|
By order of the Board of Directors,
|
|
Brian G. Drazba
|
Secretary and Chief Financial Officer
|
MEI Pharma, Inc.
|
[x], 2018
|